|Articles|March 22, 2018
ERT Launches Phase I Site Certification Program
Advertisement
ERT announced it has launched a certification program for Phase I investigative sites conducting cardiac safety studies. This program trains sites to collect precise cardiac safety data by using ERT’s proprietary Expert Precision QT approach so that trial sponsors and CROs can determine the safety of their compounds earlier in development, which can save significant time and money.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
2
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
3
Building More Representative Cancer Trial Populations
4
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
5